Antonio Marzocchi

Showing 1-13 of 13 articles

Interventions for valvular disease

Transcatheter aortic valve-in-valve implantation in degenerative rapid deployment bioprostheses

Landes U, Dvir D, Schoels W, Tron C, Ensminger S, Simonato M, Schäfer U, Bunc M, Aldea GS, Cerillo A, Windecker S, Marzocchi A, Andreas M, Amabile N, Webb J, Kornowski R

May 20, 2019 | 10.4244/EIJ-D-18-00752

Interventions for valvular disease

How should I treat an unexpected deadlock at the time of transcatheter aortic valve prosthesis implantation?

Dall’Ara G, Moretti C, Marrozzini C, Taglieri N, Saia F, Marzocchi A, Witkowski A, Kahlert P, Hildebrandt H, Lind A, Janosi R, Rassaf T

June 2, 2017 | 10.4244/EIJ-D-16-00902

Transcatheter aortic valve implantation for severe autograft regurgitation after Ross operation

Saia F, Galie N, Laborde J-C, Di Bartolomeo R, Manes A, Marzocchi A

May 20, 2014 | 10.4244/EIJV10I1A21

Percutaneous treatment of paravalvular leaks after transcatheter aortic valve implantation with the CoreValve self-expanding bioprosthesis

Saia F, Marrozzini C, Moretti C, Bordoni B, Ciuca C, Marzocchi A

June 28, 2013 | 10.4244/EIJV9I2A47

Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era

Saia F, Marrozzini C, Ciuca C, Guastaroba P, Taglieri N, Palmerini T, Bordoni B, Moretti C, Dall’Ara G, Branzi A, Marzocchi A

April 19, 2013 | 10.4244/EIJV8I12A212

Regional differences and Italian charter to expand the primary angioplasty service

De Luca L, Cremonesi A, Marzocchi A, Guagliumi G

August 25, 2012 | 10.4244/EIJV8SPA14

The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation

Saia F, Marrozzini C, Moretti C, Ciuca C, Taglieri N, Bordoni B, Dall’Ara G, Alessi L, Lanzillotti V, Bacchi-Reggiani M, Branzi A, Marzocchi A

October 28, 2011 | 10.4244/EIJV7I6A115

Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits

Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Taglieri N, Alessi L, Nardini P, Reggiani M-L, Guastaroba P, De Palma R, Grilli R, Picoco C, Gordini G, Branzi A

August 30, 2011 | 10.4244/EIJV7I4A74

Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation

Varani E, Guastaroba P, Di Tanna G, Saia F, Balducelli M, Campo G, Vignali L, Rossi R, Manari A, Piovaccari G, De Palma R, Marzocchi A

April 12, 2010

Sheiban I, La Spina C, Cavallero E, Biondi-Zoccai G, Colombo F, Palmerini T, Marzocchi A, Tamburino C, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli A, Briguori C, Vignali L, di Pede F, Ramondo A, Fantoni C, De Carlo M, Falsini G, Benassi A, Palmieri C, Filippone V, Sangiorgi D, De Servi S

February 25, 2010

Long-term clinical follow-up of drug-eluting stent restenosis treatment: retrospective analysis from two high volume catheterisation laboratories

Tagliareni F, La Manna A, Saia F, Marzocchi A, Tamburino C

January 15, 2010

Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry

Saia F, Piovaccari G, Manari A, Guastaroba P, Vignali L, Varani E, Santarelli A, Benassi A, Liso A, Campo G, Tondi S, Tarantino F, De Palma R, Marzocchi A

May 19, 2009

Percutaneous treatment of multivessel coronary disease in the drug eluting stent era: comparison of bare-metal stents, drug-eluting stents and a mixed approach in a large multicentre registry

Varani E, Saia F, Balducelli M, Guastaroba P, Marrozzini C, Tarantino F, Passerini F, Sangiorgio P, Percoco G, Grilli R, Marzocchi A, Maresta A

February 20, 2007

Latest news

New issue

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

Editorial

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

Robert Byrne

January 17, 2020

JAA

New this week: Comparing OFR & FFR, Provisional bifurcation stenting procedure and more

January 21, 2020

TRIALS BOOK

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

JAA

Last week's JAA's: Inferior caval valve implantation for severe tricuspid regurgitation

Antonio Marzocchi

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke